2-(3-Bromophenyl)-4,4,8-trimethyl-1,2,3,4-tetrahydroquinoline-6-carbonitrile

Catalog No.: 
ACYIYC027
CAS No.: 
1373546-29-2
Molecular Formula: 
C19H19BrN2
Molecular Weight: 
355.28
2-(3-Bromophenyl)-4,4,8-trimethyl-1,2,3,4-tetrahydroquinoline-6-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$560.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Bromophenyl)-4,4,8-trimethyl-1,2,3,4-tetrahydroquinoline-6-carbonitrile
IUPAC Name2-(3-bromophenyl)-4,4,8-trimethyl-1,2,3,4-tetrahydroquinoline-6-carbonitrile
MDL No.MFCD22573840
Molecular FormulaC19H19BrN2
Molecular Weight355.28
SMILESN#CC1=CC2=C(NC(C3=CC=CC(Br)=C3)CC2(C)C)C(C)=C1
InChI KeyIFBASUXCDXCIGJ-UHFFFAOYSA-N
Synonym2-(3-BROMOPHENYL)-4,4,8-TRIMETHYL-1,2,3,4-TETRAHYDROQUINOLINE-6-CARBONITRILE;6-Quinolinecarbonitrile, 2-(3-bromophenyl)-1,2,3,4-tetrahydro-4,4,8-trimethyl-
CAS No.1373546-29-2

Synthetic Route by SureRoute

1. ACYIYC027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACYIYC027 route product structure diagram
    ACYIYC0271373546-29-2
Inquiry

2. ACYIYC027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACYIYC027 route product structure diagram
    ACYIYC0271373546-29-2
Inquiry

3. ACYIYC027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYIYC027 route product structure diagram
    ACYIYC0271373546-29-2
Inquiry

Comments (0)